immune therapy

A groundbreaking study from the University of Rochester Medical Center (URMC) on Hodgkin lymphoma has demonstrated a 92% survival rate, with fewer side effects and reduced use of radiation therapy. The study, led by Dr. Johnathan Friedberg and funded by the National Cancer Institute, involved around 1,000 pediatric and adult patients, marking the first U.S. […]